Litcius/Paper detail

Selpercatinib: First approved selective RET inhibitor

Larissa Cristina Bastos de Oliveira, Lois M. Mulligan

2023Cell15 citationsDOI

Topics & Concepts

BiologyFusion proteinCell biologySmall moleculeCancer researchKinasePoint mutationMutantBiochemistryGeneRecombinant DNALung Cancer Treatments and MutationsCancer-related gene regulationCancer Genomics and Diagnostics
Selpercatinib: First approved selective RET inhibitor | Litcius